Showing results (861-870 of 1,021) with videos related to

Sort By:
Pageof 103
Environmental Monitoring and Assessment|December 10, 2015
Multi-element composition of soils of seasonal wetlands across North Dakota, USAA H Yellick, D L Jacob, E S DeKeyser, et al.
Journal of Neuro-Oncology|February 6, 2020
Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitorsSanford P C Hsu, Yi-Ching Chen, Hsin-Chien Chiang, et al.
Psychopharmacology|July 25, 2000
Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) studyV Bigliani, R S Mulligan, P D Acton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 4, 2000
Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) studyC M Stephenson, V Bigliani, H M Jones, et al.
Nuclear Medicine and Biology|March 12, 2004
A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261Rodrigo A Bressan, Kjell Erlandsson, Rachel S Mulligan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2008
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CTAshley M Groves, Gordon C Wishart, Manu Shastry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Nonlaxative PET/CT colonography: feasibility, acceptability, and pilot performance in patients at higher risk of colonic neoplasiaStuart A Taylor, Jamshed B Bomanji, Levi Manpanzure, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CTAshley M Groves, Thida Win, Nicholas J Screaton, et al.
The Journal of Clinical Investigation|June 4, 2013
Exenatide and the treatment of patients with Parkinson's diseaseIciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2015
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studiesS E Attwood, C Ell, J P Galmiche, et al.
Pageof 103